/Investor DB

Oxford Finance LLC

Venture debt

Alexandria · Growth · 42 people tracked

Find your way into Oxford Finance LLC

Sign up to see every warm intro you have to Oxford Finance LLC

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Oxford Finance LLC team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Oxford Finance's real estate and asset-based lending team focuses on the acute, post-acute, and specialty healthcare segments, financing owners and operators of properties such as skilled nursing, assisted living, memory care, and hospitals. It provides capital for working capital, acquisitions, refinancing, cash-out recapitalizations, and property transitions, lending against single assets or portfolios that are operator- or investor-owned and located in the United States. Products include working capital revolvers, senior term loans, term loan B and second lien facilities, mezzanine loans, equity and structured equity, and full capital markets capabilities, with facility sizes from $5M to $125M, tenors up to five years, initial interest-only periods, and amortization of up to 25 years.

Source: firm website, verified Sep 29, 2026.

Stage
Growth
HQ
Alexandria, Virginia, US
Leads rounds
Leads
Instruments
Debt · Equity
Founded
2002
AUM
$2.4B
Tracked investments
10
IPOs
1
Acquisitions
1

Team · 42 people

from the firm's website & public directories
J. Alden Philbrick· IV, Executive Chairman and Founderin
Ajay Nanda· Managing Director
Kevin Harbour· Managing Director
Kirk Andrews· Managing Directorin
Mark Hirsh· Managing Directorin
Nick McDearis· Managing Directorin
Peter Dahms· Managing Director
Phil Tonucci· Managing Director
Richard Russakoff· Managing Director
Sunil Annapareddy· Managing Directorin
Tanzeer Khan· Managing Director
David Hickman· Managing Director, Co-Head of Enterprise Lendingin
Garrett Henn· Managing Director, Co-Head of Enterprise Lending
Joseph Somerset· Managing Director, Portfolio Management
Austin Szafranski· Executive Director
Charles Boyle· Senior Directorin
Dorin Fachiol· Senior Directorin
Eric Schwartz· Executive Directorin
Eric Veale· Senior Directorin
Kevin Smith· Senior Directorin
Krister Anderson· Senior Director, Portfolio Management
Patrick McLenahan· Executive Director, Portfolio Managementin
Rafal Rydzewski· Senior Directorin
Amanda Stern· Director of Marketing
Desirée Williams· Associate General Counselin
John Toufanian· General Counsel & Chief Legal Officerin
Maryam Zafar· Chief Legal Officer, Enterprise Lending & Deputy General Counselin

What they invest in

from 10 of 10 portfolio companies

Biotech ×7Healthtech ×2AI & Machine Learning ×1Creator Economy ×1E-commerce ×1EdTech ×1Media & Entertainment ×1Medical Devices ×1

HQs:United States×8Canada×1

Investments · 10 tracked

founders shown can be your intro path

By year:2021 · 12020 · 12012 · 24 dated

Kyverna Therapeuticskyvernatx.cominNASDAQ: KYTXNov 2021

Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.

BiotechEmeryville, US

Warner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)Peter Maag(Executive Officer, Director)in

Co-investorsBain Capital Life SciencesVida VenturesWestlake Village BioPartnersGilead SciencesInsight PartnersKleiner Perkins+3 more

Aminonarvii.com

Narvii.com is an independent information website that publishes articles about digital platforms, online communities, and popular apps.

Creator EconomyMedia & EntertainmentSocial

Alexander Smith(Editor-in-Chief)

Co-investorsBantam GroupHighland Capital PartnersTRANSFORMATION CAPITAL

Amino Labsamino.bio𝕏

Amino Labs produces hands-on biotechnology experiment kits designed to teach genetic engineering and bacterial transformation to beginners in educational and hobbyist settings.

BiotechEdTechSouthern Alberta, CA

Julie Legault(CEO)inJustin Pahara(Biotechnology Expert)

Co-investorsSOSVThe E14 FundAccelAspect VenturesCRV (Charles River Ventures)Highland Capital Partners+1 more

Fyndfynd.comin𝕏Dec 2020 · $45MAcquired

Fynd provides a commerce platform with AI agents for sales and support, letting brands build websites, sell on marketplaces (Amazon, Myntra, Noon, Trendyol), run wholesale operations, modernise retail stores, and manage orders, payments, and logistics.

AI & Machine LearningE-commerceRetail TechSaaSSeattle, US

Farooq Adam(Founder)inSreeraman Mohan Girija(Founder)inNicolas Nezhat(President)

Co-investorsFJ LabsgrowX VenturesKae CapitalRajul Sandeep JhaveriRocketship.vcTitan Capital+7 more

Inhibrxinhibrx.comin𝕏

Inhibrx develops protein therapeutics, using target biology and protein engineering to create therapeutic candidates in clinical trials for conditions including sarcoma and head and neck cancer.

BiotechLa Jolla, US

Mark Lappe(Executive Officer, Director)inBrendan Eckelman(Director)inDoug Forsyth(Director)Jon Faiz Kayyem(Director)Margery Fischbein(Director)

BoardJudith Li(Director)

Co-investorsLAVLilly Asia VenturesRA CapitalViking Global

Nevakarnevakar.com

BiotechBridgewater, US

Navneet Puri(Executive Officer)

Co-investorsH.I.G. CapitalH.I.G. HealthBridge Partners

Sierra Oncologysierraoncology.comin𝕏

A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Co-investorsCapital Midwest FundFrazier Life SciencesLongitude CapitalRA CapitalVivo Capital

Tarsa Therapeuticstarsatherapeutics.com

Tarsa Therapeutics developed TBRIA, an oral formulation of calcitonin for treating postmenopausal osteoporosis in women more than five years post menopause when other treatments are unsuitable.

BiotechPhiladelphia, US

David Brand(Executive Officer, Director)inGregory Lumpkin(Executive Officer)

BoardRichard Kollender(Director)Martin Edwards(Director)Eric Bednarski(Director)Derek Ferguson(Director)

Co-investorsForesite CapitalMVM Life Science PartnersQuaker BioVentures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

NeoVistaSingulex

Exits · 2

1 IPOs · 1 acquisitions · showing 1

Kyverna TherapeuticsNASDAQ: KYTX

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Oxford Finance LLC made?
Oxford Finance LLC has 10 tracked investments, 2 of which have exited.
What stage does Oxford Finance LLC invest at?
Oxford Finance LLC invests at the Growth stage.
What sectors does Oxford Finance LLC focus on?
Oxford Finance LLC focuses on Biotech, Healthtech, Medical Devices, PropTech.
Where is Oxford Finance LLC located?
Oxford Finance LLC is headquartered in Alexandria, US.
Does Oxford Finance LLC lead rounds?
Yes, Oxford Finance LLC leads investment rounds.

Similar investors

Featured in lists